Positron-emission tomography and assessment of cancer therapy - PubMed (original) (raw)

Review

. 2006 Feb 2;354(5):496-507.

doi: 10.1056/NEJMra050276.

Affiliations

• PMID: 16452561
• DOI: 10.1056/NEJMra050276

Review

Positron-emission tomography and assessment of cancer therapy

Malik E Juweid et al. N Engl J Med. 2006.

No abstract available

PubMed Disclaimer

Comment in

• Positron-emission tomography in cancer therapy.
  Meyer MA. Meyer MA. N Engl J Med. 2006 May 4;354(18):1958-60; author reply 1958-60. doi: 10.1056/NEJMc060556. N Engl J Med. 2006. PMID: 16672712 No abstract available.
• Positron-emission tomography in cancer therapy.
  Aliberti S, Grignani G, Aglietta M. Aliberti S, et al. N Engl J Med. 2006 May 4;354(18):1958-60; author reply 1958-60. N Engl J Med. 2006. PMID: 16673532 No abstract available.

Similar articles

• [Usefulness of positron emission tomography in oncology].
  Fukuda H. Fukuda H. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2011;67(5):587-94. doi: 10.6009/jjrt.67.587. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2011. PMID: 21666384 Japanese. No abstract available.
• PET/CT in non-small cell lung cancer staging-promises and problems.
  Devaraj A, Cook GJ, Hansell DM. Devaraj A, et al. Clin Radiol. 2007 Feb;62(2):97-108. doi: 10.1016/j.crad.2006.09.015. Clin Radiol. 2007. PMID: 17207691 Review.
• Overview of clinical PET.
  Maisey MN. Maisey MN. Br J Radiol. 2002 Nov;75 Spec No:S1-5. doi: 10.1259/bjr.75.suppl_9.750001. Br J Radiol. 2002. PMID: 12523320 Review. No abstract available.
• Clinical PET in oncology.
  Biersack HJ, Bender H, Ruhlmann J, Oehr P, Guhlke S, Grünwald F. Biersack HJ, et al. Rev Esp Med Nucl. 2000 Jun;19(3):219-24. Rev Esp Med Nucl. 2000. PMID: 11062087 No abstract available.
• Oncological applications of FDG PET imaging.
  Delbeke D. Delbeke D. J Nucl Med. 1999 Oct;40(10):1706-15. J Nucl Med. 1999. PMID: 10520713 Review. No abstract available.

Cited by

• A priori prediction of tumour response to neoadjuvant chemotherapy in breast cancer patients using quantitative CT and machine learning.
  Moghadas-Dastjerdi H, Sha-E-Tallat HR, Sannachi L, Sadeghi-Naini A, Czarnota GJ. Moghadas-Dastjerdi H, et al. Sci Rep. 2020 Jul 2;10(1):10936. doi: 10.1038/s41598-020-67823-8. Sci Rep. 2020. PMID: 32616912 Free PMC article.
• Incidental colonic 18F-fluorodeoxyglucose uptake: do we need colonoscopy for patients with focal uptake confined to the left-sided colon?
  Lee C, Koh SJ, Kim JW, Lee KL, Im JP, Kim SG, Kim JS, Jung HC, Kim BG. Lee C, et al. Dig Dis Sci. 2013 Jan;58(1):229-35. doi: 10.1007/s10620-012-2333-y. Epub 2012 Aug 11. Dig Dis Sci. 2013. PMID: 22886593
• A Novel Framework for Automated Segmentation and Labeling of Homogeneous Versus Heterogeneous Lung Tumors in [18F]FDG-PET Imaging.
  Soufi M, Kamali-Asl A, Geramifar P, Rahmim A. Soufi M, et al. Mol Imaging Biol. 2017 Jun;19(3):456-468. doi: 10.1007/s11307-016-1015-0. Mol Imaging Biol. 2017. PMID: 27770402
• Imaging and dosimetric errors in 4D PET/CT-guided radiotherapy from patient-specific respiratory patterns: a dynamic motion phantom end-to-end study.
  Bowen SR, Nyflot MJ, Herrmann C, Groh CM, Meyer J, Wollenweber SD, Stearns CW, Kinahan PE, Sandison GA. Bowen SR, et al. Phys Med Biol. 2015 May 7;60(9):3731-46. doi: 10.1088/0031-9155/60/9/3731. Epub 2015 Apr 17. Phys Med Biol. 2015. PMID: 25884892 Free PMC article.
• Stable isotope-resolved metabolomics and applications for drug development.
  Fan TW, Lorkiewicz PK, Sellers K, Moseley HN, Higashi RM, Lane AN. Fan TW, et al. Pharmacol Ther. 2012 Mar;133(3):366-91. doi: 10.1016/j.pharmthera.2011.12.007. Epub 2011 Dec 23. Pharmacol Ther. 2012. PMID: 22212615 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database